At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

We believe Vertex is in strong financial health, given its robust cash flow generation and low debt. At the end of 2024, Vertex held about $11.2 billion in cash and equivalents.

Here's our list of the leaders in Massachusetts tech, biotech and climate tech who aren't just surviving, but moving their ...

Parnassus Growth Equity Fund (Investor Shares) returned -8.59% (net of fees) for the quarter, faring better than the Russell ...

The Invesco Health Care Fund underperformed its benchmark for the first quarter of 2025. Click here to read the full ...

CRISPR Therapeutics partnered with big biotech Vertex Pharmaceuticals ( VRTX 3.40%) on Casgevy. Although Vertex takes a ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals is making waves with its new pain treatment, Journavx, which is experiencing a prescription growth ...

Vertex Pharmaceuticals is diversifying its already strong lineup of medicines. Axsome Therapeutics has multiple clinical and ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we ...

What's driven this negative momentum is investors' concerns about the potential impact of import tariffs on corporate ...

Analysts are intrested in these 5 stocks: ( ($SKX) ), ( ($SHOP) ), ( ($FANG) ), ( ($VRTX) ) and ( ($TBCH) ). Here is a ...